Pharmaceuticals
Achalasia Treatment Market

Achalasia Treatment Market

Achalasia Treatment Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

ID: PMRREP30637

Upcoming

Author : Abhijeet Surwase

Introduction

Achalasia is rare disease which affects the esophagus making the passage of the food difficult. Achalasia is disease with unknown cause but few genetic factors as well as neuro-muscular disorders are linked to the disease. Achalasia affects the lower part of the esophagus and lowers the food passing capacity by tightening the muscles around the esophagus in turn decreasing the cavity through which food passes.

Since, achalasia is rare disease, it has higher unmet needs in the possibly best achalasia treatment. The prevalence of the achalasia is around 10 in every 100,000 of general population in the United States. The onset of the achalasia do not depend on age but it mostly affects elderly population.

Increasing awareness about incidence of achalasia and availability achalasia treatment expected to drive the growth of the achalasia treatment market. Increasing data availability about the causes, incidence, prevalence, available treatment options, literatures around the disease for better understanding further expected to drive the growth of the achalasia treatment market.

As achalasia affects older population more as compared to younger population, ageing population expected to drive the growth of the achalasia treatment market.

Various initiatives by the FDA to boost the studies carried out by various pharmaceutical and biopharmaceutical companies to evaluate the possible achalasia treatment further expected to drive the growth of the market.

FDA offers orphan drug designation to various potential molecules to be arriving in the market for the rare disease treatment, it benefits manufacturers to lower their regulatory expenditure and also offers exclusivity period post marketing which aiding to increase in the clinical studies carried out for achalasia treatment development.

The increasing number of manufacturers pursuing the evaluation of the possible effective achalasia treatment further expected to increase availability of achalasia treatment options, in turn driving the growth of the market. Whereas, the lower diagnosis rate as well as treatment seeking rate may hamper the growth of the achalasia treatment market.

Saturation of all the studies carried out for the evaluation of the achalasia treatment in the western countries further limits the potential growth of the achalasia treatment market.